Literature DB >> 22183505

Diuretic use in renal disease.

Domenic A Sica1.   

Abstract

Diuretics are agents commonly used in diseases characterized by excess extracellular fluid, including chronic kidney disease, the nephrotic syndrome, cirrhosis and heart failure. Multiple diuretic classes, including thiazide-type diuretics, loop diuretics and K(+)-sparing diuretics, are used to treat patients with these diseases, either individually or as combination therapies. An understanding of what determines a patient's response to a diuretic is a prerequisite to the correct use of these drugs. The response of patients with these diseases to diuretics, which is related to the dose, is best described by a sigmoid curve whose contour can become distorted by any of the several sodium-retaining states that are directly or indirectly associated with renal disease. Diuretic actions are of considerable importance to patients who have renal disease, as their effective use assists in extracellular fluid volume control, reducing excretion of protein in urine and lessening the risk of developing hyperkalemia. Diuretic-related adverse events that involve the uric acid, Na(+) and K(+) axes are not uncommon; therefore the clinician must be vigilant in looking for biochemical disturbances. As a result of diuretic-related adverse events, clinicians must be resourceful in the dose amount and frequency of dosing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183505     DOI: 10.1038/nrneph.2011.175

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  79 in total

Review 1.  Loop diuretics: from the Na-K-2Cl transporter to clinical use.

Authors:  Sudha S Shankar; D Craig Brater
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

2.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

3.  Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?

Authors:  F Akcicek; T Yalniz; A Basci; E Ok; E J Mees
Journal:  BMJ       Date:  1995-01-21

4.  The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.

Authors:  D W Rudy; T W Gehr; G R Matzke; W G Kramer; D A Sica; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1994-07       Impact factor: 6.875

Review 5.  Long-term adaptation of renal ion transporters to chronic diuretic treatment.

Authors:  Gheun-Ho Kim
Journal:  Am J Nephrol       Date:  2004-11-23       Impact factor: 3.754

Review 6.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Comparison of loop diuretics in patients with chronic renal insufficiency.

Authors:  J R Voelker; D Cartwright-Brown; S Anderson; J Leinfelder; D A Sica; J P Kokko; D C Brater
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

8.  Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

9.  Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.

Authors:  Nina Vasavada; Rajiv Agarwal
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  19 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

3.  Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center.

Authors:  Yusra Habib Khan; Azmi Sarriff; Azreen Syazril Adnan; Amer Hayat Khan; Tauqeer Hussain Mallhi
Journal:  Clin Exp Nephrol       Date:  2017-03-07       Impact factor: 2.801

Review 4.  Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.

Authors:  David H Ellison
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

5.  Simulating a virtual population's sensitivity to salt and uninephrectomy.

Authors:  John S Clemmer; Robert L Hester; W Andrew Pruett
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

Review 6.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

7.  Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort.

Authors:  Emily McDonald; D Michal Freedman; Bruce H Alexander; Michele M Doody; Margaret A Tucker; Martha S Linet; Elizabeth K Cahoon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

Review 8.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

Review 9.  Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.

Authors:  Carl P Walther; Vijay Nambi; Nicola A Hanania; Sankar D Navaneethan
Journal:  Am J Kidney Dis       Date:  2020-03-19       Impact factor: 8.860

10.  Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure.

Authors:  Alex M Secora; Jung-Im Shin; Yao Qiao; G Caleb Alexander; Alex R Chang; Leslie A Inker; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2020-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.